RNU7-110P

Across TCGA pan-cancer cohorts, RNU7-110P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU7-110P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU7-110P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-110P expression acts as an unfavorable survival marker, although some lineages such as BRCA and STAD show a favorable association.

MESO, ACC, and LIHC are the cancer types where RNU7-110P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.247	0.605	<.001	117	view →
ACC	DFS	Tertile	All	0.127	0.634	<.001	78	view →
LIHC	OS	Tertile	II,III,IV	0.476	0.814	<.001	51	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
SKCM	DFS	Tertile	II,III,IV	0.327	0.614	.002	30	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	27	view →
KIRC	DFS	Tertile	IV	0.204	0.521	.006	24	view →
BRCA	DFS	Tertile	III,IV	0.966	0.855	.016	18	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
STAD	OS	Quartile	III,IV	0.782	0.372	.022	10	view →
ESCA	OS	Quartile	III,IV	0.602	0.330	.030	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RNU7-110P–MESO (OS)

Open the MESO breakdown →